Max Julien

  • Citations Per Year
Learn More
We explore questions related to materiality, participation, and inclusive design that arise from a series of events involving the design and prototyping of a tennis ball for use in 'blind tennis.' We observed that the blind user-designers were full participants in the design discussion and testing phases, but were less able to take part in the construction(More)
BACKGROUND In 2006, bevacizumab, a targeted therapy agent was combined with FOLFIRI for the firstline treatment of patients with unresectable metastatic colorectal cancer. METHODS/RESULTS A study on a homogenous series of 111 patients from the Brittany and Pays de la Loire areas who received bevacizumab-FOLFIRI as first-line treatment in 2006 showed the(More)
En 2006, bevacizumab-FOLFIRI représente la thérapie ciblée administrable dès la première ligne chez les patients porteurs d’un cancer colorectal métastatique non opérable. Une série homogène de 111 patients colligés en région Bretagne et Pays de la Loire ayant reçu du bevacizumab- FOLFIRI en première ligne en 2006 révèle les résultats suivants: 51 réponses,(More)
  • 1